Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression Post author:Sam Post published:November 8, 2017 Post category:BioPharma The positive results support the company’s planned regulatory submissions. Source: BioSpace You Might Also Like Celgene Co-Founder Bags $23M for Johns Hopkins Spinout NexImmune January 1, 2018 Agile Therapeutics, Inc. Announces A Poster Presentation Of Its SECURE Phase III Study At The Conference March 16, 2017 <b>Peter Thiel</b>-Backed South San Francisco Firm Counsyl Cuts 27 Employees April 11, 2016
Agile Therapeutics, Inc. Announces A Poster Presentation Of Its SECURE Phase III Study At The Conference March 16, 2017
